Leukaemia cutis Completed Phase 3 Trials for Filgrastim (DB00099)

Also known as: Leukemia Cutis

IndicationStatusPhase
DBCOND0006922 (Leukaemia cutis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs